Clinical UM Guideline


Subject:  Penile Prosthesis Implantation
Guideline #:  CG-SURG-12Current Effective Date:  01/13/2010
Status:ReviewedLast Review Date:  11/19/2009

Description

Use of a penile prosthesis is an established technique for treating male impotence due to neurogenic or vasculogenic causes.  This document addresses the criteria for implantation of a penile prosthesis.

Clinical Indications

Medically Necessary:

The implantation of a penile prosthesis is considered medically necessary for individuals who have NOT responded to intracavernosal injection, intra-urethral medications, a vacuum constriction device and oral medications, or such treatment is not acceptable to the individual or his partner AND who meet one of the following criteria:

1.    Neurogenic impotence of greater than one year duration due to one of the following:

2. Vasculogenic impotence of greater than one year duration due to one of the following:

Not Medically Necessary: 

The implantation of a penile prosthesis is considered not medically necessary when the above criteria are not met.

Coding

The following codes for treatments and procedures applicable to this document are included below for informational purposes.  Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy.  Please refer to the member's contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.

CPT 
54400Insertion of penile prosthesis; non-inflatable (semi-rigid)
54401Insertion of penile prosthesis; inflatable (self-contained)
54405Insertion of multi-component, inflatable penile prosthesis, including placement of pump, cylinders, and reservoir
54410Removal and replacement of all component(s) of a multi-component, inflatable penile prosthesis at the same operative session
54411Removal and replacement of all components of a multi-component inflatable penile prosthesis through an infected field at the same operative session, including irrigation and debridement of infected tissue
54416Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis at the same operative session
54417Removal and replacement of a non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis through an infected field at the same operative session, including irrigation and debridement of infected tissue
  
HCPCS 
C1813Prosthesis, penile, inflatable
C2622Prosthesis, penile, non-inflatable
L8699Prosthetic implant, not otherwise specified
  
ICD-9 Procedure 
64.95Insertion or replacement of non-inflatable penile prosthesis
64.97Insertion or replacement of inflatable penile prosthesis
  
ICD-9 Diagnosis 
607.84Impotence of organic origin
Discussion/General Information

The American Urological Association (AUA) in their Guideline on the Management of Erectile Dysfunction: Diagnosis and Treatment Recommendations Management of Erectile Dysfunction define ED as the absence of hypogonadism or hyperprolactinemia in a man who develops, after a well-established period of normal erectile function, ED that is primarily organic in nature (AUA, 2005).

Damage to nerves, arteries, smooth muscles, and fibrous tissues, often as a result of disease, is the most common cause of ED. Vascular disease, and neurologic disease account for about 70 percent of ED cases. Between 35 and 50 percent of men with diabetes experience ED.

Surgery (especially radical prostate and bladder surgery for cancer) can injure nerves and arteries near the penis, causing ED. Injury to the penis, spinal cord, prostate, bladder, and pelvis can lead to ED by harming nerves, smooth muscles, arteries, and fibrous tissues of the corpora cavernosa.

Use of a penile prosthesis is an established technique for treating male impotence due to neurogenic or vasculogenic disease processes. Penile implants involve surgical insertion of malleable or inflatable rods or tubes into the penis. The surgery is not without possible complications. Minervini et al (2006) studied 447 men who had 504 penile prosthetics implanted and found that infection was the most frequent complication. Other complications were implant migration and tissue erosion.

Zermann et al (2006) studied 245 neurologically impaired men who had penile prosthetics implanted. There were 3 patient groups based on the indication for penile prosthetic surgery. Group 1 consisted of 134 participants with urinary management only; Group 2 60 participants with erectile dysfunction only, and Group 3 51 participant with urinary management and erectile dysfunction. Outcomes showed at a mean follow-up of 7.2 years (maximum 17 years) 195 patients were reevaluated in clinic. In 122 patients (90.3%) urinary management problems were resolved. Erectile dysfunction treatment was successful in 76 patients (82.6%). 43 revisions were performed for complications (e.g. infections and device perforation).

References

Peer Reviewed Publications:

  1. Henry GD, Wilson SK. Updates in inflatable penile prostheses. Urol Clin North Am. 2007; 34(4): 535-547.
  2. Israilov S, Shmuely J, Niv E, et al. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus.  Int J Impot Res. 2005; 17(5):431-436.
  3. Minervini A, Ralph DJ, Pryor JP.  Outcome of penile prosthesis implantation for treating erectile dysfunction:  experience with 504 procedures.  BJU Int. 2006; 97(1):129-133.
  4. Mulcahy JJ, Austoni E, Barada JH, et al. The penile implant for erectile dysfunction. J Sex Med. 2004; 1(1):98-109.
  5. Stephenson RA, Mori M, Hsieh YC, et al.  Treatment of erectile dysfunction following therapy for clinically localized prostate cancer:  patient reported use and outcomes from the surveillance, epidemiology and end results prostate cancer outcomes study. J Urol. 2005; 174(2):646-650.
  6. Zermann DH, Kutzenberger J, Sauerwein D, et al.  Penile prosthetic surgery in neurologically impaired patients:  long-term follow-up.  J Urol. 2006; 175(3 Pt 1):1041-1044; Discussion 1044.

Government Agency, Medical Society, and Other Authoritative Publications:

  1. The American Urological Association (AUA). Guideline on the Management of Erectile Dysfunction: Diagnosis and Treatment Recommendations. 2006. Available at: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=ed .  Accessed on October 4, 2009.
  2. American Association of Clinical Endocrinologists (AACE) Male Sexual Dysfunction Task Force.  Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Male Sexual Dysfunction:  A couple's problem.  2003 Update.  Available at: http://www.aace.com/pub/pdf/guidelines/sexdysguid.pdf . Accessed on October 5, 2009.
  3. Centers for Medicare and Medicaid Services. National Coverage Determination: Diagnosis and Treatment of Impotence. NCD #230.4. Effective date not posted. Available at: http://www.cms.hhs.gov/mcd/viewncd.asp?ncd_id=230.4&ncd_version=1&basket=ncd%3A230%2E4%3A1%3ADiagnosis+and+Treatment+of+Impotence.  Accessed on October 05, 2009.
  4. National Institutes of Health (NIH). Consensus statement: Impotence. 1992; 10(4):1-31.
  5. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Erectile Dysfunction. Available at: http://www.kidney.niddk.nih.gov/kudiseases/pubs/impotence/. Accessed on October 5, 2009.
  6. Wilt T J, Fink H A, MacDonald R, Rutks I R, Schow D. Treatment options for male erectile dysfunction: a systematic review of published studies of effectiveness. Boston, MA, USA: Veterans Affairs Medical Center, Health Services Research and Development Service, Management Decision and Research Center. Technology Assessment Program; 1999. Available at: http://www1.va.gov/resdev/resources/pubs/docs/PET_11.pdf. Accessed on October 5, 2009. 
Index

Erectile Dysfunction
Penile Prosthesis, Insertion

History

Status

Date

Action

Reviewed11/19/2009Medical Policy & Technology Assessment Committee (MPTAC) review. Place of service deleted. Discussion and references updated.
Reviewed11/20/2008MPTAC review. No change to criteria. References updated.
Reviewed11/29/2007MPTAC review. No change to criteria. References and coding were updated.
Reviewed12/07/2006MPTAC review. References updated; no change to guideline criteria.
Revised12/01/2005MPTAC review. Revision based on Pre-merger Anthem and Pre-merger WellPoint Harmonization.
Pre-Merger Organizations

Last Review Date

Document Number

Title

Anthem, Inc.

 

 No Document
Anthem BCBS

 

 No Document
WellPoint Health Networks, Inc.

12/02/2004

Clinical GuidelinePenile Prosthesis Insertion